Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/59386
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
Metadatos
Mostrar el registro completo del ítem
MOLECULAR BASIS OF ARTHRITOGENIC ALPHAVIRUS RECEPTOR MXRA8 BINDING TO CHIKUNGUNYA VIRUS ENVELOPE PROTEIN
Arthritogenic alphavirus
Chikungunya virus
MXRA8
Recepor binding
Virus entry
Human monoclonal-antibodies
Crystal-structure
Contact
Reveals
Dicam
Entry
HEK293 Cells
Autor
Afiliación
Research Network of Immunity and Health. Beijing Institutes of Life Science. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / School of Life Sciences. University of Science and Technology of China. Hefei, China.
College of Veterinary Medicine. China Agricultural University. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / School of Life Sciences. University of Science and Technology of China. Hefei, China.
Kunming Institute of Zoology. Chinese Academy of Sciences. Kunming, China.
College of Animal Sciences and Technology. Guangxi University. Nanning, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Oswaldo Cruz Foundation. Center for Technological Development in Health. National Institute of Science and Technology for Innovation on Diseases of Neglected Populations. Rio de Janeiro, RJ, Brazil.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China. / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
Oswaldo Cruz Foundation. Center for Technological Development in Health. National Institute of Science and Technology for Innovation on Diseases of Neglected Populations. Rio de Janeiro, RJ, Brazil.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China / CAS Center for Influenza Research and Early-warning. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China.
Tianjin Institute of Industrial Biotechnology. Chinese Academy of Sciences. Tianjin, China / Institute of Genetics and Developmental Biology. Chinese Academy of Sciences. Beijing, China.
Research Network of Immunity and Health. Beijing Institutes of Life Science. Chinese Academy of Sciences. Beijing, China / CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China / School of Life Sciences. University of Science and Technology of China. Hefei, China / CAS Center for Influenza Research and Early-warning. Chinese Academy of Sciences. Beijing, China / Tianjin Institute of Industrial Biotechnology. Chinese Academy of Sciences. Tianjin, China / National Institute for Viral Disease Control and Prevention. Chinese Center for Disease Control and Prevention. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / School of Life Sciences. University of Science and Technology of China. Hefei, China.
College of Veterinary Medicine. China Agricultural University. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / School of Life Sciences. University of Science and Technology of China. Hefei, China.
Kunming Institute of Zoology. Chinese Academy of Sciences. Kunming, China.
College of Animal Sciences and Technology. Guangxi University. Nanning, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Oswaldo Cruz Foundation. Center for Technological Development in Health. National Institute of Science and Technology for Innovation on Diseases of Neglected Populations. Rio de Janeiro, RJ, Brazil.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China. / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
Oswaldo Cruz Foundation. Center for Technological Development in Health. National Institute of Science and Technology for Innovation on Diseases of Neglected Populations. Rio de Janeiro, RJ, Brazil.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China / CAS Center for Influenza Research and Early-warning. Chinese Academy of Sciences. Beijing, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China.
Tianjin Institute of Industrial Biotechnology. Chinese Academy of Sciences. Tianjin, China / Institute of Genetics and Developmental Biology. Chinese Academy of Sciences. Beijing, China.
Research Network of Immunity and Health. Beijing Institutes of Life Science. Chinese Academy of Sciences. Beijing, China / CAS Key Laboratory of Pathogenic Microbiology and Immunology. Institute of Microbiology. Chinese Academy of Sciences. Beijing, China / Savaid Medical School. University of Chinese Academy of Sciences. Beijing, China / School of Life Sciences. University of Science and Technology of China. Hefei, China / CAS Center for Influenza Research and Early-warning. Chinese Academy of Sciences. Beijing, China / Tianjin Institute of Industrial Biotechnology. Chinese Academy of Sciences. Tianjin, China / National Institute for Viral Disease Control and Prevention. Chinese Center for Disease Control and Prevention. Beijing, China.
Resumen en ingles
Arthritogenic alphaviruses, such as Chikungunya virus (CHIKV), cause severe and debilitating rheumatic diseases worldwide, resulting in severe morbidity and economic costs. Recently, MXRA8 was reported as an entry receptor. Here, we present the crystal structures of the mouse MXRA8, human MXRA8 in complex with the CHIKV E protein, and the cryo-electron microscopy structure of human MXRA8 and CHIKV virus-like particle. MXRA8 has two Ig-like domains with unique structural topologies. This receptor binds in the "canyon" between two protomers of the E spike on the surface of the virion. The atomic details at the interface between the two binding entities reveal that both the two domains and the hinge region of MXRA8 are involved in interaction with CHIKV E1-E2 residues from two protomers. Notably, the stalk region of MXRA8 is critical for CHIKV virus entry. This finding provides important information regarding the development of therapeutic countermeasures against those arthritogenic alphaviruses.
Palabras clave en ingles
Adhesion moleculeArthritogenic alphavirus
Chikungunya virus
MXRA8
Recepor binding
Virus entry
Human monoclonal-antibodies
Crystal-structure
Contact
Reveals
Dicam
Entry
HEK293 Cells
Compartir